Black Diamond Therapeutics I

Penny Stocks Biotech Stocks Healthcare Stocks

$1.85

+0.10 (+5.71%)

As of Jun 30, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,841.6% upside

Low Target $30.62

Average Target $35.92

High Target $44.24

Current Price $1.85

Current
$1.85

Target
$35.92

$30.62 $35.92 avg $44.24

Scenario Analysis

Bear Case

$30.62

1,555.1%

Low target

Base Case

$35.92

+1,841.6%

Avg target

Bull Case

$44.24

+2,291.4%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$4.94

-62.6% from high

52-Week Low

$1.60

+15.6% from low

Target vs 52W High

$35.92

+627.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%